SFI
GHSI

Susquehanna Fundamental Investments’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History

Susquehanna Fundamental Investments’s Portfolio GHSI Stock Details GHSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-518
Closed -$33K – 1808
2021
Q3 		$33K Sell
518
-34
-6% -$2.26K ﹤0.01% 1669
2021
Q2 		$49K Buy
+552
New +$48K ﹤0.01% 1623

Other funds holding GHSI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna Fundamental Investments's GHSI Position: Q4 2021 in Review

Susquehanna Fundamental Investments sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q4 2021, closing a stake of 518 shares — an estimated $33K sold.

Susquehanna Fundamental Investments first reported a position in GHSI in Q2 2021 and held it in 2 quarters. The position peaked at $49K in Q2 2021. 21 funds tracked by Wall St. Rank hold GHSI as of Q4 2021.

  • Susquehanna Fundamental Investments reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 518 Guardion Health Sciences, Inc. Common Stock shares in Q4 2021, an estimated $33K.
  • Susquehanna Fundamental Investments first reported a position in Guardion Health Sciences, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Susquehanna Fundamental Investments's Guardion Health Sciences, Inc. Common Stock position peaked at $49K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q4 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2021, filed 14 Feb 2022.